Lucera Erick
- SEC CIK
- 0001697616
In the past year, 4 open-market sale filings worth $228.7K and no purchases.
Current role at each company
- DYN Dyne Therapeutics, Inc.Chief Financial Officeras of Aug 17, 2026
- SABS SAB Biotherapeutics, Inc.Directoras of Dec 18, 2025
- XAIR Beyond Air, Inc.Directoras of Nov 6, 2025
- EDIT Editas Medicine, Inc.EVP, CHIEF FINANCIAL OFFICERas of Mar 27, 2025
- BBLG Bone Biologics CorpDirectoras of Sep 20, 2023
Show 1 more company
- AVEO Aveo Pharmaceuticals, Inc.Chief Financial Officeras of Jan 19, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $228.7K
- 4 filings
- Net
- −$228.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lucera Erick as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DYN Dyne Therapeutics, Inc.
Chief Financial Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 (view filing)4:06 PM ET | Aug 13 | 4 days | Lucera ErickChief Financial Officer | SSale | −1.80K | $26.28 | −$47.2K | −1.5%119.8K after | 10b5-1 |
| Jun 26, 2026 (view filing) | Jun 25 | 1 day | Lucera ErickChief Financial Officer | SSale | −2.36K | $20.37 | −$48.1K | −1.9%121.6K after | |
| May 14, 2026 (view filing) | May 13 | 1 day | Lucera ErickChief Financial Officer | SSale | −1.45K | $18.36 | −$26.6K | −1.2%123.9K after | 10b5-1 |
| Apr 3, 2026 (view filing) | Apr 1 | 2 days | Lucera ErickChief Financial Officer | SSale | −5.73K | $18.64 | −$106.8K | −4.4%125.4K after | 10b5-1 |
EDIT Editas Medicine, Inc.
EVP, CHIEF FINANCIAL OFFICER2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 (view filing) | Mar 4 | 1 day | Lucera ErickEVP, CHIEF FINANCIAL OFFICER | SSale | −4.11K | $1.71 | −$7.03K | −3.5%112.7K after | 10b5-1 |
| May 22, 2024 (view filing) | May 20 | 2 days | Lucera ErickEVP, CHIEF FINANCIAL OFFICER | SSale | −22.3K | $5.61 | −$125.3K | −16.1%116.8K after | 10b5-1 |
XAIR Beyond Air, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2024 (view filing)5:09 PM ET | Aug 14 | 1 day | Lucera ErickDirector | PPurchase | +39.3K | $0.3964 | +$15.6K | +904.3%43.6K after | |
| Mar 20, 2023 (view filing) | Mar 16 | 4 days | Lucera ErickDirector | PPurchase | +2.00K | $6.82 | +$13.6K | +85.4%4.34K after |